The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.1508del (p.Gly503fs)

CA624860719

839947 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 38b303c0-41f2-42dd-acc1-709b4e13b1e2
Approved on: 2022-12-14
Published on: 2022-12-14

HGVS expressions

NM_000018.4:c.1508del
NM_000018.4(ACADVL):c.1508del (p.Gly503fs)
NC_000017.11:g.7224219del
CM000679.2:g.7224219del
NC_000017.10:g.7127538del
CM000679.1:g.7127538del
NC_000017.9:g.7068262del
NG_007975.1:g.9386del
NG_008391.2:g.833del
NG_033038.1:g.15327del
ENST00000356839.10:c.1508del
ENST00000322910.9:c.*1463del
ENST00000350303.9:c.1442del
ENST00000356839.9:c.1508del
ENST00000542255.6:n.366del
ENST00000543245.6:c.1577del
ENST00000578319.5:n.3del
ENST00000578711.1:n.715del
ENST00000578809.5:n.3del
ENST00000579391.1:n.116del
ENST00000579425.5:n.624del
ENST00000579546.1:n.272-102del
ENST00000579894.5:n.295del
ENST00000583074.5:n.154-102del
ENST00000583850.5:n.283del
ENST00000583858.5:n.464-102del
ENST00000585203.6:n.699del
NM_000018.3:c.1508del
NM_001033859.2:c.1442del
NM_001270447.1:c.1577del
NM_001270448.1:c.1280del
NM_001033859.3:c.1442del
NM_001270447.2:c.1577del
NM_001270448.2:c.1280del

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PM2_Supporting PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1508del (p.Gly503fs) variant in ACADVL, also known as p.Gly503GlufsTer7, is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 15/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). The highest population minor allele frequency in gnomAD v2.1.1 is 0.000008796 in the European (non-Finnish) population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting. (ACADVL VCEP specifications version 1; approved November 8, 2021
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1.1 is 0.000008796 in the European (non-Finnish) population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting).
PVS1
The c.1508del (p.Gly503fs) variant in ACADVL, also known as p.Gly503GlufsTer7, is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 15/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.